Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0650
0.00 (0.00%)
Aug 7, 2026, 5:51 PM EST
Britannia Life Sciences Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1.33 | 7.85 | 1.32 | 2.6 | 1.63 |
Short-Term Investments | 15.81 | - | - | - | - |
Cash & Short-Term Investments | 17.14 | 7.85 | 1.32 | 2.6 | 1.63 |
Cash Growth | 118.34% | 493.44% | -49.10% | 59.29% | 96.92% |
Receivables | 1.14 | 0.23 | 1.21 | 1.6 | 1.79 |
Inventory | - | - | 0.18 | - | - |
Prepaid Expenses | 0.05 | 0.02 | 0.01 | 0.02 | 0.06 |
Other Current Assets | 0.46 | 1.82 | - | - | - |
Total Current Assets | 18.79 | 9.93 | 2.73 | 4.22 | 3.48 |
Property, Plant & Equipment | 0.08 | 0.14 | 0.72 | 0.45 | 0.55 |
Long-Term Investments | 5 | 1.54 | 0.73 | 1.27 | 0 |
Goodwill | - | - | 17.78 | 17.38 | 17.06 |
Other Intangible Assets | - | - | 0.3 | 0.23 | 0 |
Other Long-Term Assets | -0 | - | - | - | - |
Total Assets | 23.87 | 11.61 | 22.26 | 23.55 | 21.09 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1.33 | 2.21 | 2.39 | 2.26 | 2.96 |
Accrued Expenses | 1.05 | 1.24 | 0.61 | 0.3 | 0.42 |
Short-Term Debt | 0.03 | 0.03 | 0.15 | 0.12 | 4.89 |
Current Portion of Long-Term Debt | 0.09 | 0.1 | 1.97 | 1.87 | - |
Current Portion of Leases | 0.08 | 0.07 | 0.11 | 0.06 | 0.05 |
Current Income Taxes Payable | 0.29 | - | - | - | - |
Other Current Liabilities | - | - | 5.27 | - | - |
Total Current Liabilities | 2.86 | 3.65 | 10.5 | 4.6 | 8.32 |
Long-Term Debt | - | 1.54 | 4.76 | 6.29 | 0.12 |
Long-Term Leases | 0.04 | 0.11 | 0.3 | 0.08 | 0.13 |
Long-Term Deferred Tax Liabilities | 0.22 | - | 0.03 | 0.1 | 0.08 |
Other Long-Term Liabilities | - | - | - | 1.42 | 6.95 |
Total Liabilities | 3.12 | 5.31 | 15.59 | 12.49 | 15.61 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 17.11 | 17.11 | 17.11 | 17.11 | 17.07 |
Additional Paid-In Capital | 3.41 | 3.41 | 3.41 | 0.16 | 0.16 |
Retained Earnings | 1.34 | -13.29 | -17.36 | -11.94 | -16.2 |
Comprehensive Income & Other | -1.1 | -0.93 | -0.72 | 1.7 | 0.32 |
Total Common Equity | 20.75 | 6.3 | 2.44 | 7.02 | 1.35 |
Minority Interest | - | - | 4.23 | 4.04 | 4.13 |
Shareholders' Equity | 20.75 | 6.3 | 6.67 | 11.06 | 5.48 |
Total Liabilities & Equity | 23.87 | 11.61 | 22.26 | 23.55 | 21.09 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 0.23 | 1.86 | 7.29 | 8.41 | 5.19 |
Net Cash (Debt) | 16.91 | 5.99 | -5.96 | -5.81 | -3.56 |
Net Cash Growth | 182.23% | - | - | - | - |
Net Cash Per Share | 0.10 | 0.04 | -0.04 | -0.04 | -0.03 |
Filing Date Shares Outstanding | 162.25 | 162.25 | 162.25 | 162.25 | 161.9 |
Total Common Shares Outstanding | 162.25 | 162.25 | 162.25 | 162.25 | 161.9 |
Working Capital | 15.93 | 6.27 | -7.77 | -0.38 | -4.84 |
Book Value Per Share | 0.13 | 0.04 | 0.02 | 0.04 | 0.01 |
Tangible Book Value | 20.75 | 6.3 | -15.64 | -10.58 | -15.71 |
Tangible Book Value Per Share | 0.13 | 0.04 | -0.10 | -0.07 | -0.10 |
Machinery | - | - | 0.78 | 0.63 | 0.56 |